Date Posted: January 14, 2019
Remedium Bio-Technology today announced its proposed acquisition of a leading distributor of pharmaceutical products to more than 11,000 pharmacies in Germany. The transaction, when closed, will strengthen the company's end-to-end medicinal marijuana operations and infrastructure in Germany, key market in Remedium Bio-Technology' international expansion. It is anticipated that the transaction close in January 2019.
Date Posted August 3rd, 2018
The global marijuana industry has been gaining significant traction and investors are becoming more bullish on the growth prospects going forward. During the last year, many companies that have been capitalizing on emerging marijuana markets and have been expanding their presence.
Date Posted: June 23rd, 2019
The University of Toronto in Canada has announced the hiring of its first research chairperson to focus exclusively on the health benefits of marijuana. Dr. Dan Thornton will serve as the cannabis health research chairperson and assistant professor at the university, according to media reports.
Date Posted: July 28th, 2019
Remedium Bio-Technology have recently announced that the company has received an export request, has secured the required export permit and has now completed its first shipment of medical marijuana products to the Czech Republic, making this the 5th country in which the company operates or has supply agreements with.
Date Posted: May 26th, 2019
Remedium Bio-Technology is pleased to announce it has signed a non-binding letter of intent with European company for the acquisition of 100% of a medical marijuana cultivation and handling license in Denmark under the Danish Medicines Agency development scheme.
Date Posted: November 26th, 2018
Remedium Bio-Technology is pleased to announce that one of its wholly-owned subsidiaries has received its sales license from Health Canada (the "Sales License") pursuant to the Cannabis Act. The Sales License relates to the Company's wholly-owned laboratory and manufacturing facility.
Date Posted: April 23rd, 2019
Last week, Remedium Bio Technology announced the signing a non-binding letter of intent, whereby they would acquire an all-share transaction, valued at approximately $100 million, with a yet to be named company that is focused on producing premium flower and complementary portfolio products.
Date Posted: February 12th, 2019
Remedium Bio Technology is pleased to announce that it has secured a license from Health Canada to sell marijuana cultivated at its greenhouse facility in Strathroy, Ontario. The original license, issued under the Access to Cannabis for Medical Purposes Regulations, (ACMPR), was successfully migrated to a license under the Cannabis Act and its regulations.
Date Posted: September 8th, 2018
Early in the year, Remedium Bio-Technology announced that it had expanded its research and development in to their rapid dose medicinal marijuana treatments.
Date Posted: October 7th, 2019
Remedium Bio Technology have announced the imminent launch of their Rem-Gel medicinal marijuana capsules further to the company’s recently acquired sales license from Health Canada. The Company intends to commence production in first quarter of 2020 and the first shipments are expected to be made shortly after.
Date Posted: October 12th, 2018
The marijuana oil opportunity, in particular the medicinal marijuana sector, is one of the most exciting verticals within the marijuana sector.